Comparative Pharmacology
Head-to-head clinical analysis: KAYEXALATE versus KIONEX.
Peer-Reviewed Evidence
Head-to-head clinical analysis: KAYEXALATE versus KIONEX.
KAYEXALATE vs KIONEX
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Kayexalate (sodium polystyrene sulfonate) is a cation-exchange resin that exchanges sodium ions for potassium ions in the gastrointestinal tract, primarily in the colon, thereby reducing serum potassium levels.
Sodium polystyrene sulfonate is a cation-exchange resin that exchanges sodium ions for potassium ions in the gastrointestinal tract, binding potassium and eliminating it via feces, thereby reducing serum potassium levels.
15-30 g orally once daily to four times daily as a suspension in water, or as a retention enema (30-50 g every 6 hours) if oral administration is not feasible.
15 to 60 grams orally once daily, or 15 grams two to four times daily, as a 15-gram powder suspension in water or juice.
None Documented
None Documented
Not applicable; the drug acts locally in the gastrointestinal tract and is not systemically absorbed.
Not applicable; the drug is not absorbed, so no systemic half-life exists. The elimination of exchanged potassium follows gastrointestinal transit.
Primarily fecal elimination of bound potassium; minimal renal elimination as the resin is not absorbed.
Primarily fecal elimination of the exchanged potassium; the resin itself is not absorbed and is excreted unchanged in feces. Renal excretion is negligible as sodium polystyrene sulfonate is not systemically absorbed.
Category C
Category C
Potassium-Removing Resin
Potassium-Removing Resin